Canopy Growth (TSX:WEED) Stock: Can It Lead the $70 Billion Cannabis Market?

Can Canopy Growth stock rebound in the second half of 2020?

| More on:
Volatile market, stock volatility

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn moresdf

Leading cannabis company Canopy Growth (TSX:WEED)(NYSE:CGC) identified Canada, the U.S., and Germany as its core markets during the recent investor day call. Canopy Growth has forecast the global cannabis market to be valued at $70 billion by 2023.

It forecast the total addressable market (TAM) at over $60 billion in the U.S. in case the product is declared legal at the federal level. It also forecasts the U.S. CBD market at $10 billion. The marijuana giant plans to launch 40 CBD products south of the border and leverage its position as a leader in this segment.

What are the challenges outlined by Canopy Growth?

While the cannabis industry is expected to grow at a rapid pace, Canopy Growth has outlined several issues plaguing marijuana producers. It claims that marijuana is not accepted as a retail product despite its legalization. Several users are still hesitant to start using these products as a result. This continues to impact demand for most licensed producers.

Another issue that continues to impact pot producers is a thriving black market. The company estimates just 40% of Canada’s cannabis users buy products from licensed producers.

How does Canopy Growth aim to surpass these challenges?

Canopy Growth revealed that it has taken multiple approaches to tackle these problems — one approach is to focus on introducing cannabis-infused alcohol drinks to consumers. It continues to focus on innovation and develop products such as vapes and gels to generate demand across product categories.

Beverage giant Constellation Brands has a 38% stake in Canopy Growth. Canopy CEO David Klein served as the CFO of Constellation Brands prior to this transition. Canopy is well poised to lead the cannabis-infused beverage market and has shipped over 500,000 beverage drinks since they were launched recently.

Canopy has forecast Canada’s beverage drinks market at $26 billion and expects to account for 5% of this space, according to a Yahoo! Finance report. This indicates an annual revenue of $1.3 billion for the company. In fiscal 2020, Canopy generated $399 million in total sales and this figure is expected to reach $539.5 million in 2021.

In order to offset lower demand due to the above-mentioned reasons as well as a slower-than-expected rollout of retail stores in major Canadian provinces, Canopy Growth is focused on reducing operating costs.

Since the start of 2020, Canopy Growth has laid off 800 employees as it aims to improve profit margins. The company expects this headcount reduction and cost-saving efforts will help it save $20 million on an annualized basis.

What next for investors?

Canopy Growth stock is trading at $23.3, which is 57% below its 52-week high and 70% below record highs. Most cannabis companies have lost massive value due to structural issues plaguing the pot industry.

Canopy Growth stock is the largest marijuana company with a market cap of $8.6 billion. It is valued at 16 times forward sales and continues to post an adjusted loss.

The pot heavyweight will have to reduce losses and drastically improve profit margins as well as grow its top-line at a rapid pace to support its lofty valuation.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

The Motley Fool owns shares of and recommends Constellation Brands. Fool contributor Aditya Raghunath has no position in any of the stocks mentioned.

More on Cannabis Stocks

Cannabis smoke
Cannabis Stocks

Canopy Growth Stock: Is Now a Good Time to Invest?

The road ahead is highly uncertain for Canopy Growth, as the stock is plagued with losses and seemingly unsurmountable industry…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

TLRY Stock: Should You Invest Now?

TLRY is a Canadian cannabis stock which is trading 91% below record highs. Let's see if you should own TLRY…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Is Tilray Stock a Buy in February 2023?

Despite the volatile cannabis sector, Tilray could be a superb buy for long-term investors.

Read more »

Young woman sat at laptop by a window
Cannabis Stocks

Is SNDL Stock a Buy in February 2023?

SNDL is a beaten-down cannabis stock. While its revenue growth is exceptional, a weak balance sheet has driven stock prices…

Read more »

A cannabis plant grows.
Cannabis Stocks

TLRY Stock: Here’s What’s Coming in 2023

Tilray Inc. (TSX:TLRY) is geared up for big growth this decade and looks like one of the top cannabis stocks…

Read more »

A person holds a small glass jar of marijuana.
Cannabis Stocks

Canopy Growth Stock: Here’s What’s Coming in 2023

Canopy Growth stock has made a lot of new moves in the last few months, but where is the company…

Read more »

A cannabis plant grows.
Cannabis Stocks

Better Cannabis Buy: Canopy Growth Stock or Tilray?

Only two TSX weed stocks can deliver substantial returns in the highly anticipated growth of the global cannabis market.

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Is Tilray Stock a Buy in January 2023?

Tilray stock has lost 50% of its value in the last 12 months, in line with its peers.

Read more »